Premium
Interleukin‐6 blockade treatment for COVID‐19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia
Author(s) -
Ranger Amita,
Haji Ruby,
Kaczmarski Richard,
Danga Akila
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16901
Subject(s) - medicine , cytokine release syndrome , immunology , tocilizumab , ards , cytokine , immune system , interleukin 6 , inflammation , immunotherapy , lung , chimeric antigen receptor , rheumatoid arthritis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom